Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 3.080
+0.020 (0.65%)
Nov 3, 2025, 12:31 PM CET
Arterra Bioscience Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Operating Revenue | 4.17 | 3.3 | 3.56 | 3.83 | 2.82 | Upgrade |
Other Revenue | 0 | 0.03 | 0.03 | 0.92 | 1.35 | Upgrade |
| 4.17 | 3.34 | 3.59 | 4.74 | 4.17 | Upgrade | |
Revenue Growth (YoY) | 25.08% | -7.10% | -24.27% | 13.64% | 18.96% | Upgrade |
Cost of Revenue | 1.76 | 1.49 | 1.15 | 1.44 | 1.26 | Upgrade |
Gross Profit | 2.41 | 1.85 | 2.44 | 3.3 | 2.91 | Upgrade |
Selling, General & Admin | 1.69 | 1.56 | 1.47 | 1.39 | 1.28 | Upgrade |
Amortization of Goodwill & Intangibles | 0.03 | 0.18 | 0.18 | 0.19 | 0.18 | Upgrade |
Other Operating Expenses | -0.99 | -1.3 | -1.16 | 0.18 | 0.03 | Upgrade |
Operating Expenses | 1.04 | 0.79 | 0.84 | 2.06 | 1.71 | Upgrade |
Operating Income | 1.37 | 1.06 | 1.6 | 1.25 | 1.2 | Upgrade |
Interest Expense | -0 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade |
Interest & Investment Income | 0.33 | 0.16 | 0.2 | - | - | Upgrade |
Earnings From Equity Investments | - | - | - | 0 | 0.01 | Upgrade |
Other Non Operating Income (Expenses) | 0 | 0.09 | 0 | 0.03 | 0 | Upgrade |
EBT Excluding Unusual Items | 1.7 | 1.3 | 1.8 | 1.27 | 1.2 | Upgrade |
Pretax Income | 1.7 | 1.3 | 1.8 | 1.27 | 1.2 | Upgrade |
Income Tax Expense | 0.36 | 0.23 | 0.38 | 0.16 | 0.09 | Upgrade |
Net Income | 1.34 | 1.08 | 1.41 | 1.11 | 1.11 | Upgrade |
Net Income to Common | 1.34 | 1.08 | 1.41 | 1.11 | 1.11 | Upgrade |
Net Income Growth | 24.21% | -23.89% | 27.33% | 0.18% | 29.32% | Upgrade |
Shares Outstanding (Basic) | 7 | 7 | - | - | - | Upgrade |
Shares Outstanding (Diluted) | 7 | 7 | - | - | - | Upgrade |
EPS (Basic) | 0.20 | 0.16 | - | - | - | Upgrade |
EPS (Diluted) | 0.20 | 0.16 | - | - | - | Upgrade |
EPS Growth | 24.21% | - | - | - | - | Upgrade |
Free Cash Flow | 0.42 | 0.96 | 1.3 | 0.86 | 0.14 | Upgrade |
Free Cash Flow Per Share | 0.06 | 0.14 | - | - | - | Upgrade |
Dividend Per Share | 0.130 | 0.100 | 0.100 | 0.050 | - | Upgrade |
Dividend Growth | 30.00% | - | 100.00% | - | - | Upgrade |
Gross Margin | 57.85% | 55.46% | 68.03% | 69.69% | 69.74% | Upgrade |
Operating Margin | 32.90% | 31.75% | 44.57% | 26.32% | 28.79% | Upgrade |
Profit Margin | 32.03% | 32.26% | 39.38% | 23.42% | 26.57% | Upgrade |
Free Cash Flow Margin | 10.15% | 28.77% | 36.23% | 18.05% | 3.30% | Upgrade |
EBITDA | 1.71 | 1.59 | 2.13 | 1.74 | 1.6 | Upgrade |
EBITDA Margin | 41.02% | 47.70% | 59.38% | 36.60% | 38.39% | Upgrade |
D&A For EBITDA | 0.34 | 0.53 | 0.53 | 0.49 | 0.4 | Upgrade |
EBIT | 1.37 | 1.06 | 1.6 | 1.25 | 1.2 | Upgrade |
EBIT Margin | 32.90% | 31.75% | 44.57% | 26.32% | 28.79% | Upgrade |
Effective Tax Rate | 21.44% | 17.36% | 21.33% | 12.83% | 7.56% | Upgrade |
Revenue as Reported | 5.27 | 4.95 | 5.3 | 4.61 | 4.31 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.